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Clinical significance of therapeutic drug 
monitoring
Suzana Mimica Matanović
University Clinical Center Osijek, Osijek, Croatia
Therapeutic drug monitoring (TDM) represents an 
important way to optimise dosing of a wide range 
of drugs. Optimal drug therapy includes attaining 
the desired pharmacological effect of the drug, 
while reaching the maximal effect in the shortest 
possible time and decreasing the risk of toxicity. 
Clinicians request TDM in order to monitor patient 
compliance, individualize therapy at the beginning 
of therapy or when the dose is changed, diagnose 
undertreatment, avoid drug toxicity and manage 
withdrawal of the therapy.
Individual drug and drug classes where the most 
clinical usefulness of TDM is gained include 
aminoglycoside antibiotics (e.g. gentamicin), van-
comycin, immunosuppressants (e.g. tacrolimus, 
cyclosporine), digoxin, theophylline, methotrex-
ate, tricyclic antidepressants, lithium and antiepi-
leptic drugs (AED). Digoxin is less often used than 
before but it is essential to regularly monitor its 
concentration for it can be associated with fatal 
adverse drug reactions in case of toxic concentra-
tions (e.g. severe arrhythmias), especially in pa-
tients with compromised renal function.
TDM of AEDs will most likely benefit the individual 
patient through assessing compliance (particularly 
in patients with uncontrolled outbreak through 
seizures), through detecting drug toxicity, guiding 
dosage adjustment in situations with increased 
pharmacokinetic variability (e.g., children, the eld-
erly, drug formulation changes) and in situations 
when important pharmacokinetic change is antici-
pated (e.g., in pregnancy). Pregnancy is particular-
ly challenging in patients receiving AEDs because 
those drugs are associated with increased risk of 
congenital malformations, while physiological 
changes during pregnancy result in a reduction in 
the serum concentrations of most AEDs. Increase 
in lamotrigine clearance is particularly marked, 
leading to significant fall in plasma concentrations 
and consequent breakthrough seizures in some 
women. Concentrations may rise after delivery, 
leading to lamotrigine toxicity. Regular monitoring 
of AEDs is advised in each trimester and shortly af-
ter delivery and more frequent monitoring has 
been recommended for lamotrigine.
Corresponding author: mimica-matanovic.suzana@kbo.hr
Clinical chemist’s interpretative 
competence in toxicology
Maksimiljan Gorenjak
University Clinical Center Maribor, Maribor, Slovenia
The role of laboratory, and specially the role of 
clinical chemist, in detection of disease, based on 
action of toxins (intoxication), is not well defined. 
In reality, a clinician can (may) frequently detect 
the cause of intoxication with simple-direct obser-
vation of patient’s clinical condition. Moreover, the 
clinical staff usually share the same opinion, that 
the laboratory analytics is performed only to con-
firm their judgment and to fill the patient’s admin-
istrative documentation, but has no influence on 
course of treatment. Such thinking produces fre-
quently the confusion between the laboratory 
personnel and represents an usual companion in 
clinical laboratories. An additional embarrassment 
is the lasting education and the lack of properly 
educated personnel for toxicological analytics. 
Such consideration is changed because the tech-
niques and knowledge in (clinical) laboratories has 
developed. The determination of kind (type) and 
quantity of absorbed substances can relieve the 
course of treatment. The laboratory findings can 
be used for optimization of therapy, and addition-
al treatment can be carefully performed (dialysis, 
haemoperfusion, antidote therapy). In some cases, 
even a negative result could be of crucial impor-
tance. However, the time is of crucial importance, 
and only the quick and effective analytics with 
proper results interpretation, has some value. 
There is a high agreement in the literature about 
the frequency of different intoxications. Far ahead 
are intoxications with medicaments and alcohol, 
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followed by drugs of abuse, mushrooms, food, 
chemicals from agriculture and gases. Clinical lab-
oratories with their facilities perform number of 
analyses, which can be used as an aid in diagnosis 
of intoxication. Such analyses are complete blood 
count, concentration of sodium, potassium, chlo-
ride, urea, creatinine, glucose, calcium, magnesium, 
albumin, INR, liver tests, anion gap, serum osmolali-
ty and osmolality gap, blood gas analysis, some 
enzymes (pseudocholinesterase, creatine kinase) 
etc. With proper interpretation this data can be 
very helpful and of benefit for intoxicated patient.
Corresponding author: gormax@ukc-mb.si
Toxicology in forensic medicine
Vesna Horvat
University Clinical Center Osijek, Osijek, Croatia
Forensic toxicology is a discipline that deals with 
the medical aspects of the harmful effects of xe-
nobiotics on humans and animals, helps in deter-
mining death and determines the circumstances 
that results in death. It connects the natural sci-
ences (biology and chemistry) and social science 
(law) as it deals with a trial testimony in legal pro-
cedures relating to various poisonings.
Often, only external examination and autopsy of 
the body cannot determine the cause of death. 
Therefore, the court medics (but also the court and 
the lawyers) require toxicological analysis at every 
sudden, unexplained death circumstances, traffic 
accidents, homicides or suicides.
The basic prerequisite for good toxicological anal-
ysis is certainly an appropriate sample, properly 
collected and stored. Samples in forensic process-
ing dead bodies include body fluids, tissues and 
contents of the digestive organs. For reliable re-
sults of the toxicological analysis good laboratory 
equipment and trained personnel are also very im-
portant.
There are no “absolute” rules in interpretation of 
toxicology results. Results cannot be interpreted 
only on the basis of the so-called “normal” or “ref-
erence” values. In the interpretation of toxicologi-
cal results except concentrations of xenobiotics in 
the blood it must be taken into account the sam-
pling site of blood (blood samples from different 
sites may give different results), but also the rate of 
absorption of xenobiotics, bioavailability, volume 
of distribution, half-life and the rate of metabolism 
which are different from person to person and are 
rarely known for the deceased person. Also, it is 
very important to take into account all the infor-
mation about the circumstances and events relat-
ed to the case of poisoning, particularly just before 
death, because toxicological results should be in-
terpreted in light of the police documents (investi-
gation) and the findings of medical tests.
Finally, forensic toxicologist report can be used as 
evidence in court, and based on the results ob-
tained, may seek its interpretation and opinion.
Corresponding author: phorvat.vesna@gmail.com
Instrumental techniques in toxicology
Željko Debeljak
University Clinical Center Osijek, Osijek, Croatia
Huge chemical diversity of substances that may 
cause intoxication generates high demands for se-
lectivity and sensitivity of analytical methods and 
instruments needed for determination of these 
substances in different biological matrices. Diver-
sity of chemical properties of analytes and matri-
ces is reflected in variety of different analytical in-
struments used in toxicology laboratory and in the 
reduced potential for analytical process automa-
tion.
During the last few decades some analytical tech-
niques proved to be the most versatile and be-
came standard tools in analytical toxicology. These 
techniques include gas chromatography coupled 
to mass detectors, liquid chromatography coupled 
to the tandem mass detectors and atomic absorp-
tion spectroscopy. Basic principles and limitations 
Biochemia Medica 2014;24(2):A1–A5   
A4
Abstracts of the 25th Symposium Croatian Society of Medical Biochemistry and Laboratory Medicine
of these techniques are given in this presentation. 
Specific sample preparation requirements are also 
described. Besides standard techniques, the utility 
of some older, less reliable methods like immu-
noassays is discussed. Relevant properties of some 
emerging techniques like time-of-flight mass spec-
trometry or less frequently used techniques like 
enzyme assays and capillary electrophoresis are 
shortly described at the end of this presentation.
Corresponding author: debeljak.zeljko@kbo.hr
Implementation of new techniques in 
toxicology
Sanja Mandić
University Clinical Center Osijek, Osijek, Croatia
Analytical toxicology deals with the detection, 
identification and measurement of xenobiotics in 
biological fluids, tissues and other specimens with 
the purpose of diagnosis, management and pre-
vention of poisoning. Different techniques and 
methods are available for analysis of various com-
pounds, but of the greatest interest is the field of 
pharmaceuticals and drugs of abuse analysis.
Great progress in drug discovery methodology is 
observed in the latter part of twentieth century 
with introduction of the modern instrumental 
techniques. Since then, a range of powerful novel 
technologies, especially techniques related to 
mass spectrometric methods are constantly evolv-
ing, bringing new and better solutions and mak-
ing them attractive and more toxicologicaly in-
formative. However, comprehensive analysis that 
can detect all drugs in the sample with adequate 
sensitivity does not exist yet.
The choice of method and instrument in analytical 
toxicology depends on the problems to be solved. 
Many factors must be considered like the nature of 
analyte supposed to be determined, sample ma-
trix, expected concentrations, whether qualitative 
or quantitative analysis is required and the time 
available for the analysis. Hence, knowledge about 
desirable characteristics of the instrument is nec-
essary to ensure required information. It is particu-
larly important in the selection of detector and 
gases. The choice of instrument may influence the 
choice of sample preparation which is important 
for selection of appropriate equipment and space. 
Finally, such techniques pose requirements related 
to space, security, maintenance and servicing. 
Mentioned requirements will be described 
through examples of implementation of selected 
techniques in the University Clinical Centre Osijek.
Corresponding author: mandic.sanja@gmail.com
Pharmacogenomics in personalized 
laboratory medicine, a new opportunity 
for more effective and safer treatment
Janja Marc*1, Ron van Schaik2, Matthias Schwab3, Ivan 
Brandslund4, Chiara Di Resta5, Pieter Vermeersch6, Elvar 
Theodorsson7, Mario Pazzagli8
*on behaf of EFLM-ESPT Working group on Personalized 
Laboratory Medicine
1Ljubljana, Slovenia; 2Roterdam, Netherland; 3Stutgart, 
Germany; 4Vejle, Denmark; 5Milan, Italy; 6Leuven, Belgium; 
7Linköping, Sweden; 8Florence, Italy.
Physicians, pharmacists and also laboratory medi-
cine professionals are aware for a long time that 
theory “one fits all” is no longer valid. The tailoring 
of drug dosing or drug selection was recognized 
as crucial for higher drug efficacy and lower ad-
verse drug effects as well as for cost-effectiveness 
of (biological) drug treatments. Genetic factors are 
one of many factors (along with for example kid-
ney or liver dysfunction) influencing treatment ef-
ficacy and safety. Pharmacogenomics (PGx) is 
looking for the genetic changes of proteins in-
volved in drug absorption, metabolism, elimina-
tion and therefore the genetic changes which 
could alter drug plasma levels (pharmacokinetics) 
or drug-target interactions (pharmacodynamics). 
PGx testing as DNA testing of an individual has 
therefore the potential for significant contribution 
to individualization of treatment. PGx is taking an 
important part in personalized medicine, which 
represent a new approach in patients manage-
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ment and is based on molecular definition of dis-
eases. The long time research in the field of phar-
macogenomics (PGx) resulted in much important 
information on molecular basis of drug efficacy, in-
dividual drug response and especially of predic-
tion of adverse drug effects. Our study of the mo-
lecular basis of imatinib resistance in patients with 
Ph-positive chronic myeloid leukaemia and role of 
drug transporters at raloxifen treatment will be 
presented in the talk. In general, pharmacogenom-
ics shift the emphasis in medicine from the reac-
tion to the prevention and from population to in-
dividual patient with the aim to avoid medical 
complications and to reduce the healthcare costs. 
However, the use of PGx testing is still not widely 
used in clinical practice. Only some of clinical 
chemistry labs are performing the PGx testing for 
thiopurines, clopidogrel, codeine, warfarin, 
abacavir, simvastatin and allopurinol treatments. 
Steadily increasing evidence for the benefits of 
PGx in several drug treatments schemes is likely to 
result in the wider entrance of PGx into laboratory 
medicine in the near future.
*Corresponding author: Janja.Marc@ffa.uni-lj.si
Liquid chromatography- mass 
spectrometry and applications of 
therapeutic drug monitoring
Mateja Šter*, Milan Skitek
University Medical Center Ljubljana, Ljubljana, Slovenia
To the present time therapeutic drug monitoring 
(TDM) - the quantitative determination of drugs in 
biological fluids in clinical laboratories has been 
predominantly performed using automated im-
munoassays. But it is recognised that immunoassay 
methods can suffer with non-specific interference 
from related compounds, metabolite interference 
or matrix effects. In recent years, liquid chroma-
tography (LC) coupled to mass spectrometry (MS) 
has also expanded in routine clinical laboratories. 
It provides higher analytical sensitivity and specifi-
city and it has ability to develop methods in a more 
rapid time frame than immunoassays. LC-MS as-
says for most therapeutic drugs have been devel-
oped; however in clinical practice are just some of 
them, most often immunosuppressants and new-
er drugs.
Voriconazole and posaconazole are two triazole 
antifungals administered for the prevention and in 
the treatment of invasive fungal infections. Be-
cause of their broad inter- and intra-individual 
pharmacokinetic variability, TDM is suggested to 
be used for dose optimization.
We have developed a convenient assay for deter-
mination of voriconazole and posaconazole in se-
rum by LC-MS. Sample preparation involved a sim-
ple one-step protein precipitation with acetonitrile. 
After centrifugation, the supernatant was injected 
directly into the HPLC with C18 reversed-phase 
column. Mass spectrometric detection was per-
formed using electrospray ion source in positive 
ionization mode, with ion trap mass spectrometer 
we used the fragmentation transitions m/z 
350.0  → m/z 126.9 and m/z 701.3 → m/z 683.3 for 
voriconazole and posaconazole, respectively. The 
retention time of voriconazole was 4.7 min and of 
posaconazole was 5.0 min. Standard curves were 
linear over the concentration range of 0.1 to 12 
mg/L. Intra- and interday coefficients of variation 
(imprecision) were 6.4 and 12.7 for voriconazole 
and 5.3 and 12.9 for posaconazole. The recovery 
was 99.6 for voriconazole and 96.8 for posacona-
zole. This simple and rapid LC-MS assay offer an ef-
ficient method for TDM of antifungals voricona-
zole and posaconazole.
*Corresponding author: mateja.ster@kclj.si
